New radiation technique could replace brachytherapy for cervical cancer

NCT ID NCT06560697

Recruiting now Disease control Sponsor: National Institute of Cancerología Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a newer radiation technique called SABR with standard brachytherapy for treating locally advanced cervical cancer. About 84 women will receive either SABR or brachytherapy after initial chemo-radiation. The goal is to see if SABR is as safe and effective, which could help hospitals that lack brachytherapy equipment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation therapy (SABR or brachytherapy)
What this could lead to: If successful, this could provide an effective alternative to brachytherapy for cervical cancer, making treatment more accessible for hospitals without brachytherapy equipment.
What could go wrong: This is a phase 2 trial with only 84 participants, so results are preliminary. SABR may not be as effective or safe as brachytherapy, and long-term outcomes are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UTERINE CERVICAL NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UTERINE CERVICAL NEOPLASM

Contacts and locations

Locations

Instituto Nacional de Cancerologia
RECRUITING

Mexico City, Tlalpan, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.